Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
January-2026 Volume 31 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
January-2026 Volume 31 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

Adiposity indices and bone health amongst Malaysian adults: Evidence from a cross‑sectional study

  • Authors:
    • Wenjian Zhao
    • Weizheng Zhang
    • Kok-Yong Chin
    • Xiaodong Ma
    • Hashwin Singh Tejpal Singh
    • Sophia Ogechi Ekeuku
    • Yuanzhong Wang
    • Xia Ji
    • Yang Guo
    • Sok Kuan Wong
    • Norliza Muhammad
    • Teh Rohaila Jamil
    • Saharuddin Ahmad
  • View Affiliations / Copyright

    Affiliations: Department of Pathology, College of Basic Medicine, Xiangnan University, Chenzhou, Hunan 423043, P.R. China, Department of Nursing, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Kuala Lumpur 56000, Malaysia, Department of Pharmacology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Kuala Lumpur 56000, Malaysia, Department of Traditional Chinese Medicine, Universiti Tunku Abdul Rahman, Kajang, Selangor 43000, Malaysia, Department of Nursing, School of Medicine, Shaanxi University of International Trade and Commerce of Pharmacy College, Xianyang, Shaanxi 712046, P.R. China, Department of Family Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Kuala Lumpur 56000, Malaysia
    Copyright: © Zhao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 28
    |
    Published online on: November 21, 2025
       https://doi.org/10.3892/etm.2025.13023
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The relationship between adiposity and bone health is controversial because of the various direct and indirect bone regulatory functions of adipose tissue. Given the limitations of the body mass index (BMI) as a reliable marker of adiposity, several alternative indices have been developed. The different indices show varying associations with bone health. The present study aimed to determine the association between various adiposity indices and bone health amongst Malaysians. In October and November 2024, this cross‑sectional study recruited 320 subjects (231 women and 89 men) from a bone health screening event via purposive sampling. The subjects' body weight, height, and waist and hip circumference were measured, and adiposity indices [BMI, waist‑to‑hip ratio (WHR), waist‑to‑height ratio (WtHR), body roundness index (BRI), conicity index (CI) and a body shape index (ABSI)] were derived from these basic parameters. The subjects' bone health was evaluated by using a calcaneal bone quantitative ultrasonometer‑derived osteoporosis index (OI). Linear regression analysis was used to determine the relationship between adiposity indices and bone health after adjustment for potential confounders. The strength of association was indicated as beta coefficient (β). The results indicated that after adjustment for confounders, a significant relationship existed between the OI and all adiposity indices, with the exception of CI. The BMI (β=0.172, P<0.001), waist circumference (β=0.184, P=0.001), WHR (β=0.124, P=0.025), WtHR (β=0.160, P=0.002) and BRI (β=0.165, P=0.001) showed a positive association with bone health, whereas the ABSI (β=‑0.183, P=0.008) showed a negative association. In conclusion, adiposity indices associated with body size showed a positive relationship with bone health, whereas the ABSI, which has already been adjusted for body size, showed a negative relationship with bone health.

Introduction

Osteoporosis, a metabolic disease affecting millions of older adults globally, is represented by the deterioration of bone mass and microarchitecture, leading to fragility fracture (1). Dual-energy X-ray absorptiometry (DXA) is the gold-standard method for diagnosing osteoporosis. It quantifies bone mineral density (BMD) as a surrogate of bone strength. However, DXA is not portable and emits ionising radiation. Therefore, it is unsuitable for deployment in mass bone health screening. These limitations can be overcome with quantitative ultrasonometry (QUS), which provides alternative measures of bone health (2). Previous studies have established that QUS indices predict osteoporosis/osteopenia (3,4) and fracture risk (5) and may reflect microarchitecture (6).

Apart from being female and menopausal, being underweight is a major risk factor for osteoporosis (7,8). A low body weight negatively impacts bone health by acting as a surrogate for malnutrition or exerting low mechanical loading on bone (9). Mechanical loading is important to stimulate bone repair and maintain bone health (10). Previous studies have firmly established body weight and the body mass index (BMI) as positive predictors of bone health status (11). Obesity, defined by BMI, is found to decrease the odds of osteoporosis by 70.1% (11). The BMI is reflective of body size but may not reflect adiposity status correctly (12). It underestimates the degree of adiposity in patients with sarcopenia but overestimates that in athletes (12). The relationship between adiposity and bone health remains controversial even after the delineation of the effects of the BMI (13).

Adiposity may be a double-edged sword for bone health. On the positive side, it exerts mechanical loading on bone; such loading stimulates bone mass accrual to support a person's weight (14). Adipose tissue also synthesises oestrogens, which are beneficial for bone health (15). Furthermore, the hyperinsulinaemia that is often associated with obesity can increase bone mass because of the anabolic action of insulin (16).

On the negative side, adiposity is associated with chronic inflammation, a state known to cause bone loss. Adipokines secreted by adipocytes, such as adiponectin and resistin, can actively promote bone loss (17,18). Meanwhile, leptin's role is complex: It can be either pro- or antiosteogenic depending on whether it regulates bone health through central or peripheral pathways (19). Therefore, the net effect of adiposity on bone health remains debatable.

Other indices have been developed as alternatives in consideration of the limitations of the BMI in reflecting adiposity. Waist circumference (WC) (20), waist-to-hip ratio (WHR) (21), waist-to-height ratio (WtHR) (22), a body shape index (ABSI) (23), body roundness index (BRI) (24) and conicity index (CI) (25), derived from body anthropometric measurements, can predict cardiometabolic risks well. The relationship between these alternative adiposity indices and bone health has been explored. However, most studies that investigated these relationships are derived from the databases of the National Health and Nutrition Examination Survey on the United States population (26-32), whereas those from other geographical regions are sparse (33-37). Heterogenous findings, whereby negative and positive relationships between adiposity indicated by the above indices and bone health have been observed, have been obtained. These gaps suggest that additional studies on diverse populations should be implemented.

The present study attempts to address the above research gaps by comparing the associations between various adiposity indices and bone health measured via calcaneal QUS amongst Malaysians. It will help clarify the effect of adiposity on bone health. Its findings are particularly important for Malaysians at two levels. Firstly, Malaysia is rapidly advancing to an ageing society, with 15% of the overall population projected to be aged 60 years or above by 2030(38). Secondly, Malaysians have a combined obesity and overweight prevalence of 54.4% (39). The compounded effects of ageing and obesity could have an influence on the prevalence of osteoporosis in Malaysia. Therefore, the present study offers insight into adiposity as an interventional target in osteoporosis.

Patients and methods

Ethical considerations

The study protocol was reviewed and approved by the Universiti Kebangsaan Malaysia Ethics Committee (Kuala Lumpur, Malaysia; approval code: JEP-2024-739). Subjects were briefed on the details of the study and provided written informed consent before participating.

Subject recruitment

This cross-sectional study was conducted from October 2024 to November 2024 in conjunction with the institutional Osteoporosis Month programme. Subjects were recruited through purposive sampling, in which all individuals who met the selection criteria were invited to participate in the study. The purposive sampling strategy was adopted because of the nature of the health screening event. The screening site was the lobby of Hospital Canselor Tuanku Muhriz, affiliated with Universiti Kebangsaan Malaysia (Kuala Lumpur, Malaysia). The researchers were aware of the biases carried by the recruitment strategy. These biases are discussed amongst the limitations of the study.

The subjects included were adult Malaysians aged 20 years and above. They were excluded if they declared having medical conditions affecting bone health (such as Paget's disease, osteogenesis imperfecta, osteomalacia, rickets, hyper/hypothyroidism, hyper/hypoparathyroidism and chronic kidney diseases) or taking medication that affects bone health [such as glucocorticoids, sex hormones, aromatase inhibitors, androgen deprivation therapy, anticoagulants (heparin and warfarin), loop diuretics, chemotherapeutics, anticonvulsants, antidepressants, thiazolidinediones and antiretrovirals].

Sample size calculation

Sample size was calculated by using G*Power version 3.1.97 (Heinrich-Heine-Universität) with input effect size=0.15 (moderate effect size by convention), alpha error=0.05, power=0.8 and number of predictors (variables of interest and confounders)=16. The calculated minimum sample was 143.

Confounder measurements

The subjects answered a demographic, lifestyle and medical history questionnaire that has been used in previous bone health studies (40). Their date of birth and citizenship were identified from their national registration identity card. Their biological sex, ethnicity, household income, pre-existing medical conditions and medical use were self-declared. The lifestyle questionnaire explores the subjects' habits in smoking cigarettes and consuming alcohol, dairy products, tea and coffee. Female subjects answered additional questions on menstrual status.

Anthropometric measurements

The subjects' waist circumference at the midpoint between the lowest point of the ribcage and highest point of the iliac crest was determined by using a measuring tape. Hip circumference was measured at the widest part of the gluteal muscle. The subjects' height without shoes was measured with a stadiometer. These three measurements were recorded to the nearest 1 cm. The subjects' body weight while wearing light clothing without shoes was recorded by using a scale (BC353; Accunic) to the nearest 0.1 kg.

Calculation of adiposity indices

The adiposity indices BMI (41), WHR (42), WtHR (43), ABSI (23), BRI (44) and CI (45) were calculated on the basis of the formulas shown in Table I.

Formula for calculating indices of
adiposity.

Table I

Formula for calculating indices of adiposity.

Bone health measurements

The bone health of the subjects was quantified by using a calcaneal bone sonometer (OSTEOKJ3000; Kejin) and recorded as speed of sound (SOS) and broadband ultrasound attenuation (BUA). The osteoporosis index (OI) was calculated automatically by using the formula OI=0.106 x SOS + 0.5 x BUA-127.4, as preset by the manufacturer. The subject inserted their nondominant foot into the holder. Two oil-filled balloon transducers were inflated to touch the lateral sides of the calcaneus, which had been cleaned with alcohol and covered with ultrasonic gel. Ultrasound was transmitted through the calcaneal bone and the device interpreted signals. Each subject was measured two times and a third reading was taken when the previous two readings were inconsistent. The categorisation of subjects based on T-score or Z-score was not performed in the present study because the World Health Organisation's cut-offs apply only to DXA. Therefore, raw OI values were used to reflect the bone health of the subject, in which a high value indicates good bone health.

Statistical analysis

The Kolmogorov-Smirnov test was used to test for data normality. The subjects' characteristics were compared between men and women by using an independent-samples t-test for normally distributed parameters and the Mann-Whitney U-test for skewed data. Comparison between categorical variables was conducted by employing the Chi-squared test or Fisher's exact test. Multiple linear regression was used to investigate the association between OI and bone health, with adjustment for potential confounders, such as age, sex, ethnicity, status of smoking (yes or former/no), status of alcohol use (yes or former/no), status of regular milk/tea/coffee consumption (yes/no), calcium supplements (yes/no), self-reported fracture (yes/no), self-reported parental fracture (yes/no), self-reported height reduction (yes/no), use of medication (yes/no) and presence of comorbidities (yes/no). Cook's distance was employed to identify multivariate outliers, which were subsequently removed to ensure the generalisability of the models. Associations were reported in the form of B and β values. Statistical analysis was performed by utilising SPSS version 26 (IBM, Corp.). The data were expressed as mean standard ± deviation and n (%). P<0.05 was considered to indicate a statistically significant difference.

Results

Subject characteristics

The present study recruited 320 subjects (231 women and 89 men) within the study period. The mean age of the subjects was 50.1±16.7 years. The height, weight, waist circumference, WHR, WtHR, CI, BRI, ABSI, skeletal muscle mass, visceral fat area, BUA and OI of men were significantly higher compared with women (P>0.05). The body fat percentage of women was significantly higher compared with men (P>0.05; Table II). Significantly more men were regular cigarette smokers and alcohol consumers (P<0.05). Significantly more women were regular coffee and calcium supplement consumers (P<0.05). The distributions of ethnicity, regular milk and tea consumption, self-reported fracture history, parental fracture history and height reduction were not significantly different between sexes (P>0.05; Table III).

Table II

Subject's age, body composition and calcaneal quantitative ultrasonometry data.

Table II

Subject's age, body composition and calcaneal quantitative ultrasonometry data.

ParameterTotal (n=320)Women (n=231)Men (n=89)P-value
Age, years50.1±16.750.0±16.050.5±18.50.802
Height, cm159.8±8.4156.1±5.2169.4±7.5<0.001
Weight, kg66.8±16.463.4±14.275.6±18.5 <0.001a
Body weight index, kg/m226.1±5.626.0±5.726.2±5.50.770a
Waist circumference, cm85.1±12.082.1±10.192.7±13.2<0.001
Waist-to-hip ratio0.89±0.090.87±0.070.94±0.120.009b
Waist-to-height ratio0.53±0.070.53±0.070.55±0.070.017
Conicity index1.21±0.061.19±0.031.28±0.06<0.001
Body roundness index4.08±1.463.96±1.394.39±1.610.024a
A body shape index0.077±0.0040.075±0.0020.081±0.003 <0.001b
Skeletal muscle mass, kg24.9±5.422.6±3.330.8±5.4 <0.001c
Fat mass, kg21.6±8.922.2±8.520.1±9.70.060
Body fat percentage, %31.5±7.233.8±5.925.3±6.9<0.001
Visceral fat area, cm299.1±52.090.7±47.2120.9±57.8 <0.001a
Speed of sound, m/sec1,530.3±26.51,528.9±24.11,533.9±31.90.183
Broadband attenuation of sound, dB/MHz25.1±6.124.1±5.727.5±6.5<0.001
Osteoporosis index47.0±5.446.4±4.948.6±6.20.003

[i] aThe values were normalized using square-root transformation before being compared;

[ii] bthe values were compared using Mann-Whitney U-test;

[iii] cthe values were normalized using logarithmic transformation before being compared. Values are expressed as the mean ± standard deviation.

Table III

Subject characteristics.

Table III

Subject characteristics.

ItemTotal (n=320)Women (n=231)Men (n=89)P-value
Ethnicity   0.145
     Malay180 (56.3)137 (59.3)43 (48.3) 
     Chinese113 (35.3)79 (34.2)34 (38.2) 
     Indian18 (5.6)10 (4.3)8(9) 
     Others9 (2.8)5 (2.2)4 (4.5) 
Menstrual status   NR
     Regular105 (45.5)105 (45.5)NR 
     Irregular16 (6.9)16 (6.9)NR 
     Menopausal110 (47.6)110 (47.6)NR 
Regular smokinga   <0.001
     No303 (94.7)227 (98.3)76 (85.4) 
     Yes17 (5.3)4 (1.7)13 (14.6) 
Regular alcohol drinking   0.009
     No304(95)224(97)80 (89.9) 
     Yes16(5)7(3)9 (10.1) 
Regular milk consumption   0.845
     No195 (60.9)140 (60.6)55 (61.8) 
     Yes125 (39.1)91 (39.4)34 (38.2) 
Regular coffee drinking   0.021
     No161 (50.3)107 (46.3)54 (60.7) 
     Yes159 (49.7)124 (53.7)35 (39.3) 
Regular tea drinking   0.289
     No177 (55.3)132 (57.1)45 (50.6) 
     Yes143 (44.7)99 (42.9)44 (49.4) 
Regular calcium supplement   0.018
     No228 (71.3)156 (67.5)72 (80.9) 
     Yes92 (28.7)75 (32.5)17 (19.1) 
Self-reported fracture history   0.962
     No280 (87.5)202 (87.4)78 (87.6) 
     Yes40 (12.5)29 (12.6)11 (12.4) 
Self-reported parental fracture   0.151
     No273 (85.3)193 (83.5)80 (89.9) 
     Yes47 (14.7)38 (16.5)9 (10.1) 
Self-reported height reduction   0.238
     No280 (87.5)199 (86.1)81(91) 
     Yes40 (12.5)32 (13.9)8(9) 

[i] aFisher's exact test was used instead of Pearson's Chi-square because >20% of cells have a count <5. Values are expressed as n (%). NR, not relevant.

Association between bone health and adiposity indices

Linear regression revealed a positive association between OI and BMI (β=0.212, P<0.001), waist circumference (β=0.268, P<0.001), WtHR (β=0.190, P=0.001), CI (β=0.151, P=0.007) and BRI (β=0.203, P<0.001) before adjustment for confounders (Table IV, Model 1). After adjustment for confounders (Table IV, Model 2), a significant positive association was found between OI and BMI (β=0.172, P<0.001), waist circumference (β=0.184, P=0.001), WHR (β=0.124, P=0.025), WtHR (β=0.160, P=0.002) and BRI (β=0.165, P=0.001). A significant negative association was found between OI and ABSI (β=-0.183, P=0.008). The changes in the regression coefficient with the increment of confounders are presented in Table SI. The associations between OI and adiposity indices were consistent in each model, showing their robustness.

Table IV

Association between bone health (osteoporosis index) and adiposity indices.

Table IV

Association between bone health (osteoporosis index) and adiposity indices.

  Model 1Model 2
ParameternaBSEβP-valueBSEβP-value
Body mass index3000.1890.050.212<0.0010.1520.0430.172<0.001
Waist circumference3000.1050.0220.268<0.0010.0720.0210.1840.001
Waist-to-hip ratio3021.1823.0240.0220.7006.4852.8740.1240.025
Waist-to-height ratio30213.7564.1110.1900.00111.5813.6250.160.002
Conicity index30214.6475.3670.1510.0077.1067.0780.0730.316
Body roundness index3020.6950.1940.203<0.0010.5660.1710.1650.001
A body shape index2985.52979.6680.0040.945-251.31194.264-0.1830.008

[i] aThe number of subjects in each model is <320 due to the removal of multivariate outliers/influential cases. This is to ensure the generalizability of the models. Model 1 is unadjusted. Model 2 is adjusted for age, sex, ethnicity, status of smoking (yes or former/no), alcohol use status (yes or former/no), regular milk/tea/coffee consumption status (yes/no), calcium supplements (yes/no), self-reported fracture (yes/no), self-reported parental fracture (yes/no), self-reported height reduction (yes/no), medication use (yes/no), presence of co-morbidities (yes/no). SE, standard error.

Discussion

The present cross-sectional study found a positive association between bone health and BMI, waist circumference, WHR, WtHR, CI and BRI and a negative association between bone health and ABSI amongst Malaysians. It found no significant association between bone health and CI.

In the present study, the BMI was found to be positively associated with bone health. This observation agrees with the authors' previous findings on Malaysian men aged >20 years that revealed a positive relationship between BMI and bone health, as indicated by QUS (46). As mentioned earlier, underweight is well recognised as a strong risk factor for osteoporosis (7,8). A Mendelian randomisation study demonstrated a causal relationship between BMI and BMD; however, this relationship is site-specific (47). A high BMI was found to causally increase the BMD at the lumbar spine and calcaneus but exerts no effects on forearm and femoral neck BMD (47). This association is likely driven by mechanical loading (11). However, the relationship between the BMI and bone health is highly complex. A meta-analysis reported a low risk of vertebral fracture with a high BMI in men, whereas the inverse was observed in women after adjustment for BMD (48). Another meta-analysis found that an increased BMI was associated with trabecular microarchitecture deterioration (49). Therefore, an increased BMI associated with BMD does not always translate into improved bone quality.

In this work, bone health was positively associated with the waist circumference, WHR, WtHR and BRI. Given that these indices were not adjusted for the BMI, they could act as surrogate measures for body size, reflecting the relationship between mechanical loading and bone health. This observation was supported by other studies that indicated a positive association between the above indices and BMD (37) or a negative association between the above indices and osteoporosis risk (29,31,50). Nevertheless, other studies reported contradictory results (32,34,51). These controversies may be explained by a nonlinear relationship between these indices and bone health (U-shape) and sex differences in this relationship (52). As a result of the limited number of male subjects, a sex-based subanalysis was not performed in the present study.

CI was positively associated with bone health in the adjusted model. However, this association weakened after adjustment for potential confounders. CI primarily reflects central adiposity and, indirectly, the effects of body size and mechanical loading on bone, thereby explaining the above positive association. Nevertheless, this association is weak and not independent of the covariates studied. While CI is a useful cardiometabolic risk marker, it may not effectively predict bone health. Another study comparing the association between various anthropometric indices and osteoporosis risk found that CI did not perform as well as BRI and WtHR (53).

In this research, bone health was negatively associated with ABSI. Similar findings were obtained by previous studies (27,28,30,34-36,54), which reported low BMD and high osteoporosis risk. Given that the calculation of ABSI accounts for BMI, ABSI may accurately reflect the adiposity status independent of body size. It has been shown to correlate with visceral adiposity without being influenced by body weight (55). Visceral fat has a more significant association with systemic inflammation and metabolic dysregulation than subcutaneous fat (56). These underlying mechanisms could explain the negative association between ABSI and bone health observed in the present study. However, given that inflammatory cytokine and adipokine levels were not determined in the subjects of this research, this mechanistic explanation remains speculative.

Several limitations should be noted before generalising the results of the present study. The cross-sectional nature of this work prevents causal inference between adiposity and bone health. The subjects' recruitment from a health screening programme is prone to suffering from selection and volunteer biases. Therefore, the characteristics of these subjects might differ from those of the general population. For example, the subjects who volunteered for the present study may be more health-conscious than the general population. Conversely, they may have specific health concerns that motivated them to participate in the research. The nonrandomised sampling approach also prevented the authors from comparing the baseline characteristics of the subjects with those of a national representative cohort, such as the cohort included in the National Health and Morbidity Survey of Malaysia, to verify the extent of sampling bias. The small sizes of subgroups (based on sex, ethnicity and BMI status) also prevented the authors from investigating the relationship between variables in different contexts. Certain studies have demonstrated that the association between the adiposity index and bone health can be influenced by sex and diabetes status (28,52), and most have revealed consistent associations (26,31,32). A study found that the connection between adiposity and bone health differs by sex in older adults (52). For postmenopausal women, the relationship is U-shaped: Both very low and very high adiposity levels are associated with poor bone health. This may be because low body fat limits their postmenopausal oestrogen production (57), which supports bone health, while high body fat promotes chronic inflammation that damages bones. For older men, the relationship is linear, meaning bone health simply declines as adiposity increases, likely due to the damaging effects of chronic inflammation.

Regarding the bone health assessment tool, QUS is not the gold standard for diagnosing osteoporosis despite its portability and safety features. Its T- and Z-scores cannot be used interchangeably with the values generated by DXA because of differences in reference values and technology. In the present study, the physical activity levels of the subjects were excluded from the analysis because the subjects had difficulty in accurately recalling their physical activities. Bone health biochemical markers, such as circulating vitamin D, calcium and phosphorus levels, were not determined in this research because blood collection was not performed in the health screening session. Nevertheless, this work provides novel insights into the relationship between adiposity and bone health and affirms that ABSI could be considered as a risk factor for osteoporosis in the general population.

In conclusion, amongst Malaysians, adiposity indices unadjusted for body size, such as the BMI, waist circumference, WHR, WtHR, CI and BRI, are positively associated with the bone health index measured by QUS. By contrast, ABSI, which accounts for body size, shows a negative association with the bone health index. The findings of this work suggest that ABSI may be a useful marker for identifying individuals at risk of poor bone health in the Malaysian population. However, its critical value and clinical effectiveness still require further substantial validation before it can be reliably used as a routine risk assessment tool.

Supplementary Material

Changes in association between bone health (osteoporosis index) and adiposity indices with increasing adjustments.

Acknowledgements

The authors thank Associate Professor Bo Ma (Department of Traditional Chinese Medicine, The First People's Hospital of Sishui County, Jining, China) for lending the QUS bone ultrasonometer. The authors also thank Ms. Tianru Ruan, Nanjing Kejing Industrial Co., Ltd. (Nanjing, Jiangsu, China) for technical support in data retrieval of QUS. The authors also thank Ms Goh Li Lian (School of Medicine, IMU University, Bukit Jalil, Selangor, Malaysia) for assistance in the literature search.

Funding

Funding: Universiti Kebangsaan Malaysia funded the study via the Fundamental Research Grant (grant no. FF-2024-403).

Availability of data and materials

The data generated in the present study may be requested from the corresponding author.

Authors' contributions

KYC, NM, SKW, TRJ and SA were involved in the conceptualisation of the study and acquired funding. KYC, WjZ, YW, XJ and YG performed data curation. KYC performed formal analysis, project administration and supervision. WjZ, WzZ, KYC, XM, HSTS, SOE, YW, XJ and YG performed investigations. KYC, NM, SKW, TRJ and SA were responsible for methodology. WjZ, WzZ and XM provided resources. WjZ, WzZ and KYC wrote the original draft. NM, SKW, TRJ and SA reviewed and edited the manuscript. KYC and WjZ confirm the authenticity of all the raw data. All authors have read and approved the final manuscript.

Ethics approval and consent to participate

The Universiti Kebangsaan Malaysia Ethics Committee approved the present study (Kuala Lumpur, Malaysia; approval no: JEP-2024-739) and participants provided informed consent prior to participation.

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Use of artificial intelligence tools

During the preparation of this work, artificial intelligence tools [ChatGPT 3.0 (OpenAI)] were used to improve the readability and language of the manuscript, and subsequently, the authors revised and edited the content produced by the artificial intelligence tools as necessary, taking full responsibility for the ultimate content of the present manuscript.

References

1 

Chin KY, Ng BN, Rostam MKI, Muhammad Fadzil NFD, Raman V, Mohamed Yunus F, Syed Hashim SA and Ekeuku SO: A mini review on osteoporosis: From biology to pharmacological management of bone loss. J Clin Med. 11(6434)2022.PubMed/NCBI View Article : Google Scholar

2 

Chin KY and Ima-Nirwana S: Calcaneal quantitative ultrasound as a determinant of bone health status: What properties of bone does it reflect? Int J Med Sci. 10:1778–1783. 2013.PubMed/NCBI View Article : Google Scholar

3 

Jiang Y, Wu H, Yang D, Wang W, Chu J, Tang J and Yao X: Diagnostic value of quantitative ultrasound for osteoporosis in elderly women: A meta-analysis. Altern Ther Health Med. 30:226–231. 2024.PubMed/NCBI

4 

Subramaniam S, Chan CY, Soelaiman IN, Mohamed N, Muhammad N, Ahmad F, Ng PY, Jamil NA, Aziz NA and Chin KY: The performance of a calcaneal quantitative ultrasound device, CM-200, in stratifying osteoporosis risk among malaysian population aged 40 years and above. Diagnostics (Basel). 10(178)2020.PubMed/NCBI View Article : Google Scholar

5 

Fu Y, Li C, Luo W, Chen Z, Liu Z and Ding Y: Fragility fracture discriminative ability of radius quantitative ultrasound: A systematic review and meta-analysis. Osteoporos Int. 32:23–38. 2021.PubMed/NCBI View Article : Google Scholar

6 

Olmos JM, Hernández JL, Pariente E, Martínez J, Valero C and González-Macías J: Trabecular bone score and bone quantitative ultrasound in Spanish postmenopausal women. The Camargo Cohort Study. Maturitas. 132:24–29. 2020.PubMed/NCBI View Article : Google Scholar

7 

Liu Y, Huang X, Tang K, Wu J, Zhou J, Bai H, Zhou L, Shan S, Luo Z, Cao J, et al: Prevalence of osteoporosis and associated factors among Chinese adults: A systematic review and modelling study. J Glob Health. 15(04009)2025.PubMed/NCBI View Article : Google Scholar

8 

Tong X, Cui S, Shen H and Yao XI: Developing and validating a nomogram prediction model for osteoporosis risk in the UK biobank: A national prospective cohort. BMC Public Health. 25(1263)2025.PubMed/NCBI View Article : Google Scholar

9 

Park SM, Park J, Han S, Jang HD, Hong JY, Han K, Kim HJ and Yeom JS: Underweight and risk of fractures in adults over 40 years using the nationwide claims database. Sci Rep. 13(8013)2023.PubMed/NCBI View Article : Google Scholar

10 

Ma Q, Miri Z, Haugen HJ, Moghanian A and Loca D: Significance of mechanical loading in bone fracture healing, bone regeneration, and vascularization. J Tissue Eng. 14(20417314231172573)2023.PubMed/NCBI View Article : Google Scholar

11 

Liu Y, Liu Y, Huang Y, Le S, Jiang H, Ruan B, Ao X, Shi X, Fu X and Wang S: The effect of overweight or obesity on osteoporosis: A systematic review and meta-analysis. Clin Nutr. 42:2457–2467. 2023.PubMed/NCBI View Article : Google Scholar

12 

Sweatt K, Garvey WT and Martins C: Strengths and limitations of BMI in the diagnosis of obesity: What is the path forward? Curr Obes Rep. 13:584–595. 2024.PubMed/NCBI View Article : Google Scholar

13 

Hou J, He C, He W, Yang M, Luo X and Li C: Obesity and bone health: A complex link. Front Cell Dev Biol. 8(600181)2020.PubMed/NCBI View Article : Google Scholar

14 

Gkastaris K, Goulis DG, Potoupnis M, Anastasilakis AD and Kapetanos G: Obesity, osteoporosis and bone metabolism. J Musculoskelet Neuronal Interact. 20:372–381. 2020.PubMed/NCBI

15 

Steiner BM and Berry DC: The regulation of adipose tissue health by estrogens. Front Endocrinol (Lausanne). 13(889923)2022.PubMed/NCBI View Article : Google Scholar

16 

Ravindran S, Wong SK, Mohamad NV and Chin KY: A review of the relationship between insulin and bone health. Biomedicines. 13(1504)2025.PubMed/NCBI View Article : Google Scholar

17 

Shu L, Fu Y and Sun H: The association between common serum adipokines levels and postmenopausal osteoporosis: A meta-analysis. J Cell Mol Med. 26:4333–4342. 2022.PubMed/NCBI View Article : Google Scholar

18 

Tariq S, Tariq S, Khaliq S and Lone KP: Serum resistin levels and related genetic variants are associated with bone mineral density in postmenopausal women. Front Endocrinol (Lausanne). 13(868120)2022.PubMed/NCBI View Article : Google Scholar

19 

Cosme D and Gomes AC: Leptin levels and bone mineral density: A friend or a foe for bone loss? A systematic review of the association between leptin levels and low bone mineral density. Int J Mol Sci. 26(2066)2025.PubMed/NCBI View Article : Google Scholar

20 

Nevill AM, Duncan MJ and Myers T: BMI is dead; long live waist-circumference indices: But which index should we choose to predict cardio-metabolic risk? Nutr Metab Cardiovasc Dis. 32:1642–1650. 2022.PubMed/NCBI View Article : Google Scholar

21 

Cheng CH, Ho CC, Yang CF, Huang YC, Lai CH and Liaw YP: Waist-to-hip ratio is a better anthropometric index than body mass index for predicting the risk of type 2 diabetes in Taiwanese population. Nutr Res. 30:585–593. 2010.PubMed/NCBI View Article : Google Scholar

22 

Tewari A, Kumar G, Maheshwari A, Tewari V and Tewari J: Comparative evaluation of waist-to-height ratio and BMI in predicting adverse cardiovascular outcome in people with diabetes: A systematic review. Cureus. 15(e38801)2023.PubMed/NCBI View Article : Google Scholar

23 

Bertoli S, Leone A, Krakauer NY, Bedogni G, Vanzulli A, Redaelli VI, De Amicis R, Vignati L, Krakauer JC and Battezzati A: Association of Body Shape Index (ABSI) with cardio-metabolic risk factors: A cross-sectional study of 6081 Caucasian adults. PLoS One. 12(e0185013)2017.PubMed/NCBI View Article : Google Scholar

24 

Xu J, Zhang L, Wu Q, Zhou Y, Jin Z, Li Z and Zhu Y: Body roundness index is a superior indicator to associate with the cardio-metabolic risk: Evidence from a cross-sectional study with 17,000 Eastern-China adults. BMC Cardiovasc Disord. 21(97)2021.PubMed/NCBI View Article : Google Scholar

25 

Kheirouri S and Alizadeh M: Contribution of body adiposity index and conicity index in prediction of metabolic syndrome risk and components. Human Nutrition & Metabolism. 38(200290)2024.

26 

Wu J and Wu G: Association between a body shape index and bone mineral density in US adults based on NHANES data. Sci Rep. 15(2817)2025.PubMed/NCBI View Article : Google Scholar

27 

Wu M, Lu B, Wang Y, Zhang A, Zhou X, Zeng X, Zhu Y, Chen S and Lin R: The association between A in body shape index and total bone mineral density adults aged 20 to 59 NHANES 2011 to 2018. Medicine (Baltimore). 104(e42652)2025.PubMed/NCBI View Article : Google Scholar

28 

Zhang M, Hou Y, Ren X, Cai Y, Wang J and Chen O: Association of a body shape index with femur bone mineral density among older adults: NHANES 2007-2018. Arch Osteoporos. 19(63)2024.PubMed/NCBI View Article : Google Scholar

29 

Li H, Qiu J, Gao Z, Li C and Chu J: Association between waist-to-height ratio and osteoporosis in the National health and nutrition examination survey: A cross-sectional study. Front Med (Lausanne). 11(1486611)2024.PubMed/NCBI View Article : Google Scholar

30 

Niu HG, Hu GK, Li T, Guo Z, Hu Y, Gong YK, Ye GQ, Chen DJ, An JL and Gao WS: Association of a body shape index with bone mineral density and osteoporosis among U.S. adults: Evidence from NHANES. Calcif Tissue Int. 116(76)2025.PubMed/NCBI View Article : Google Scholar

31 

Zhang X, Liang J, Luo H, Zhang H, Xiang J, Guo L and Zhu X: The association between body roundness index and osteoporosis in American adults: Analysis from NHANES dataset. Front Nutr. 11(1461540)2024.PubMed/NCBI View Article : Google Scholar

32 

Ding Z, Zhuang Z, Tang R, Qu X, Huang Z, Sun M and Yuan F: Negative association between body roundness index and bone mineral density: Insights from NHANES. Front Nutr. 11(1448938)2024.PubMed/NCBI View Article : Google Scholar

33 

Deng G, Yin L, Li K, Hu B, Cheng X, Wang L, Zhang Y, Xu L, Xu S, Zhu L, et al: Relationships between anthropometric adiposity indexes and bone mineral density in a cross-sectional Chinese study. Spine J. 21:332–342. 2021.PubMed/NCBI View Article : Google Scholar

34 

Zhao X, Sun J, Xin S and Zhang X: Association between new anthropometric indices and osteoporosis in Chinese postmenopausal women-retrospective study based on hospitalized patients in China. Front Endocrinol (Lausanne). 16(1535540)2025.PubMed/NCBI View Article : Google Scholar

35 

Xiong MF, He P, Chen YH, Cao RR and Lei SF: The effect of a body shape index (ABSI) and its interaction with low estimated glomerular filtration rate (eGFR) on osteoporosis in elderly Chinese. J Orthop Sci. 29:262–267. 2024.PubMed/NCBI View Article : Google Scholar

36 

Kim B, Kim GM, Kim E, Park J, Isobe T, Mori Y and Oh S: The anthropometric measure ‘a body shape index’ may predict the risk of osteoporosis in middle-aged and older Korean people. Int J Environ Res Public Health. 19(4926)2022.PubMed/NCBI View Article : Google Scholar

37 

Murat S, Dogruoz Karatekin B, Demirdag F and Kolbasi EN: Anthropometric and body composition measurements related to osteoporosis in geriatric population. Medeni Med J. 36:294–301. 2021.PubMed/NCBI View Article : Google Scholar

38 

Abdullah JM, Ismail A and Yusoff MSB: Healthy ageing in Malaysia by 2030: Needs, challenges and future directions. Malays J Med Sci. 31:1–13. 2024.PubMed/NCBI View Article : Google Scholar

39 

Tee ES and Voon SH: Combating obesity in Southeast Asia countries: Current status and the way forward. J Glob' Health. 8:147–151. 2024.

40 

Chan CY, Subramaniam S, Mohamed N, Ima-Nirwana S, Muhammad N, Fairus A, Ng PY, Jamil NA, Abd Aziz N and Chin KY: Determinants of bone health status in a multi-ethnic population in klang valley, Malaysia. Int J Environ Res Public Health. 17(384)2020.PubMed/NCBI View Article : Google Scholar

41 

Weir CB and Jan A: BMI Classification Percentile And Cut Off Points. Journal 2023.

42 

Obesity in Asia Collaboration. Is central obesity a better discriminator of the risk of hypertension than body mass index in ethnically diverse populations? J Hypertens. 26:169–177. 2008.PubMed/NCBI View Article : Google Scholar

43 

Ashwell M, Gunn P and Gibson S: Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: Systematic review and meta-analysis. Obes Rev. 13:275–286. 2012.PubMed/NCBI View Article : Google Scholar

44 

Tao L, Miao L, Guo YJ, Liu YL, Xiao LH and Yang ZJ: Associations of body roundness index with cardiovascular and all-cause mortality: NHANES 2001-2018. J Hum Hypertens. 38:120–127. 2024.PubMed/NCBI View Article : Google Scholar

45 

Martins CA, do Prado CB, Santos Ferreira JR, Cattafesta M, Dos Santos Neto ET, Haraguchi FK, Marques-Rocha JL and Salaroli LB: Conicity index as an indicator of abdominal obesity in individuals with chronic kidney disease on hemodialysis. PLoS One. 18(e0284059)2023.PubMed/NCBI View Article : Google Scholar

46 

Chin KY, Soelaiman IN, Mohamed IN, Ibrahim S and Wan Ngah WZ: The effects of age, physical activity level, and body anthropometry on calcaneal speed of sound value in men. Arch Osteoporos. 7:135–145. 2012.PubMed/NCBI View Article : Google Scholar

47 

Song J, Zhang R, Lv L, Liang J, Wang W, Liu R and Dang X: The relationship between body mass index and bone mineral density: A mendelian randomization study. Calcif Tissue Int. 107:440–445. 2020.PubMed/NCBI View Article : Google Scholar

48 

Kaze AD, Rosen HN and Paik JM: A meta-analysis of the association between body mass index and risk of vertebral fracture. Osteoporos Int. 29:31–39. 2018.PubMed/NCBI View Article : Google Scholar

49 

Kusuman K, Wiryadana KA, Setiawan IMB and Rante SDT: Body mass index inversely associated with bone microarchitecture quality: A systematic review and meta-analysis. IJBS. 16:28–33. 2022.

50 

Chen R, Zhao W, Cai P, Peng C and Liu H: The association between body roundness index and risk of osteoporosis in patients with type 2 diabetes mellitus: A cross-sectional study based on NHANES database. J Orthop Surg (Hong Kong). 33(10225536251356804)2025.PubMed/NCBI View Article : Google Scholar

51 

Tian N, Chen S, Han H, Jin J and Li Z: Association between triglyceride glucose index and total bone mineral density: A cross-sectional study from NHANES 2011-2018. Sci Rep. 14(4208)2024.PubMed/NCBI View Article : Google Scholar

52 

Chen PJ, Lu YC, Lu SN, Liang FW and Chuang HY: Association between osteoporosis and adiposity index reveals nonlinearity among postmenopausal women and linearity among men aged over 50 years. J Epidemiol Glob Health. 14:1202–1218. 2024.PubMed/NCBI View Article : Google Scholar

53 

Zhang J, Wang Y, Guo J, Liu H, Lei Z, Cheng S and Cao H: The association between ten anthropometric measures and osteoporosis and osteopenia among postmenopausal women. Sci Rep. 15(10994)2025.PubMed/NCBI View Article : Google Scholar

54 

Zhao Z, Ji H, Liu W, Wang Z, Ren S, Liu C, Wu C, Wang J and Ding X: The saturation effect of a body shape index on lumbar bone mineral density in US adults: Findings from a nationwide survey. PLoS One. 20(e0324160)2025.PubMed/NCBI View Article : Google Scholar

55 

Ryotaro B, Masahiro A, Norihiko O, Nakano Y, Takeuchi T, Murakami M, Sasahara Y, Numasawa M, Minami I, Izumiyama H, et al: Indirect measure of visceral adiposity ‘A Body Shape Index’ (ABSI) is associated with arterial stiffness in patients with type 2 diabetes. BMJ Open Diabetes Res Care. 4(e000188)2016.PubMed/NCBI View Article : Google Scholar

56 

Yu JY, Choi WJ, Lee HS and Lee JW: Relationship between inflammatory markers and visceral obesity in obese and overweight Korean adults: An observational study. Medicine (Baltimore). 98(e14740)2019.PubMed/NCBI View Article : Google Scholar

57 

Hetemäki N, Savolainen-Peltonen H, Tikkanen MJ, Wang F, Paatela H, Hämäläinen E, Turpeinen U, Haanpää M, Vihma V and Mikkola TS: Estrogen metabolism in abdominal subcutaneous and visceral adipose tissue in postmenopausal women. J Clin Endocrinol Metab. 102:4588–4595. 2017.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhao W, Zhang W, Chin K, Ma X, Tejpal Singh H, Ogechi Ekeuku S, Wang Y, Ji X, Guo Y, Wong SK, Wong SK, et al: Adiposity indices and bone health amongst Malaysian adults: Evidence from a cross‑sectional study. Exp Ther Med 31: 28, 2026.
APA
Zhao, W., Zhang, W., Chin, K., Ma, X., Tejpal Singh, H., Ogechi Ekeuku, S. ... Ahmad, S. (2026). Adiposity indices and bone health amongst Malaysian adults: Evidence from a cross‑sectional study. Experimental and Therapeutic Medicine, 31, 28. https://doi.org/10.3892/etm.2025.13023
MLA
Zhao, W., Zhang, W., Chin, K., Ma, X., Tejpal Singh, H., Ogechi Ekeuku, S., Wang, Y., Ji, X., Guo, Y., Wong, S. K., Muhammad, N., Jamil, T., Ahmad, S."Adiposity indices and bone health amongst Malaysian adults: Evidence from a cross‑sectional study". Experimental and Therapeutic Medicine 31.1 (2026): 28.
Chicago
Zhao, W., Zhang, W., Chin, K., Ma, X., Tejpal Singh, H., Ogechi Ekeuku, S., Wang, Y., Ji, X., Guo, Y., Wong, S. K., Muhammad, N., Jamil, T., Ahmad, S."Adiposity indices and bone health amongst Malaysian adults: Evidence from a cross‑sectional study". Experimental and Therapeutic Medicine 31, no. 1 (2026): 28. https://doi.org/10.3892/etm.2025.13023
Copy and paste a formatted citation
x
Spandidos Publications style
Zhao W, Zhang W, Chin K, Ma X, Tejpal Singh H, Ogechi Ekeuku S, Wang Y, Ji X, Guo Y, Wong SK, Wong SK, et al: Adiposity indices and bone health amongst Malaysian adults: Evidence from a cross‑sectional study. Exp Ther Med 31: 28, 2026.
APA
Zhao, W., Zhang, W., Chin, K., Ma, X., Tejpal Singh, H., Ogechi Ekeuku, S. ... Ahmad, S. (2026). Adiposity indices and bone health amongst Malaysian adults: Evidence from a cross‑sectional study. Experimental and Therapeutic Medicine, 31, 28. https://doi.org/10.3892/etm.2025.13023
MLA
Zhao, W., Zhang, W., Chin, K., Ma, X., Tejpal Singh, H., Ogechi Ekeuku, S., Wang, Y., Ji, X., Guo, Y., Wong, S. K., Muhammad, N., Jamil, T., Ahmad, S."Adiposity indices and bone health amongst Malaysian adults: Evidence from a cross‑sectional study". Experimental and Therapeutic Medicine 31.1 (2026): 28.
Chicago
Zhao, W., Zhang, W., Chin, K., Ma, X., Tejpal Singh, H., Ogechi Ekeuku, S., Wang, Y., Ji, X., Guo, Y., Wong, S. K., Muhammad, N., Jamil, T., Ahmad, S."Adiposity indices and bone health amongst Malaysian adults: Evidence from a cross‑sectional study". Experimental and Therapeutic Medicine 31, no. 1 (2026): 28. https://doi.org/10.3892/etm.2025.13023
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team